<CVDATargets>
    <Condition name="HYP">
        <Targets>
            <Target><![CDATA[BP (under 80) 140-159/90-99]]></Target>
            <Target><![CDATA[BP (under 80) 160-179/100-119]]></Target>
            <Target><![CDATA[HT & CVD not on LLT]]></Target>
            <Target><![CDATA[HT & CVD high non-HDLc]]></Target>
	        <Target><![CDATA[BP 160-179/100-119]]></Target>
	        <Target><![CDATA[BP>180/120]]></Target>
		</Targets>
    </Condition>
	<Condition name="CHOL">
		<Targets>
			<Target><![CDATA[CVD not on LLT]]></Target>
			<Target><![CDATA[CVD no lipid test]]></Target>
			<Target><![CDATA[FH not on lipid treatment]]></Target>
			<Target><![CDATA[Coded as FH]]></Target>
			<Target><![CDATA[30 Plus FH case finder]]></Target>
			<Target><![CDATA[Under 30 FH case finder]]></Target>
		</Targets>
	</Condition>
    <Condition name="CKD">
        <Targets>
            <Target><![CDATA[CKD & HT & ACR>70 BP>130]]></Target>
            <Target><![CDATA[CKD & HT & ACR<70 BP>140]]></Target>
            <Target><![CDATA[CKD & CVD not on LLT]]></Target>
            <Target><![CDATA[CKD & CVD high non-HDLc]]></Target>
	        <Target><![CDATA[CKD no ACR]]></Target>
	        <Target><![CDATA[CKD & DM or ACR>=22.6 no SGLT2i]]></Target>
	        <Target><![CDATA[eGFR monitor Gp 4]]></Target>
	        <Target><![CDATA[eGFR monitor Gp 3]]></Target>
	        <Target><![CDATA[eGFR monitor Gp 2]]></Target>
	        <Target><![CDATA[eGFR monitor Gp 1]]></Target>
	        <Target><![CDATA[CKD with 25% fall in eGFR]]></Target>
	        <Target><![CDATA[CKD & DM & ACR>=3 no RAA]]></Target>
	        <Target><![CDATA[CKD & ACR>=70 no RAA]]></Target>
	        <Target><![CDATA[CKD & ACR>=22.6 no RAA]]></Target>
	        <Target><![CDATA[CKD & HT & ACR>=30 no RAA]]></Target>
        </Targets>
    </Condition>
</CVDATargets>

